SS-31 Pre-Mixed Pen 25mg
SS-31 pre-mixed Pen 25mg facilitates ATP synthesis to improve mitochondrial activity and total energy generation. According to research, this supplement may lower the inflammatory cytokines associated with Alzheimer’s, Parkinson’s, cardiovascular, diabetes, and renal disease.
SS-31 pre-mixed pen is a short peptide capable of penetrating mitochondria and influencing the maintenance of mitochondrial activity. SS-31 is a member of a class of cell-penetrating peptides that accumulate and target the inner mitochondrial membrane. It repairs the mitochondria by binding to cardiolipin, an essential part of the mitochondria’s inner membrane.
Neuroprotective Advantages:
SS-31 protects against anaesthesia-induced cognitive problems and promotes mitochondrial function, synaptic health, and wellness in mice. But no research studies have tested its neuroprotective results in humans.
Ageing and associated health problems:
Preliminary findings from temporary phase I/II clinical trials recommend a possible benefit of SS-31 peptide in patients with cardiac arrest. Research studies are required to confirm this.
Research findings
The Szeto-Schiller peptide SS-31, also called Bendavid, mainly interacts with CL to change the shape of the membrane layer and stop the damage from peroxidation. It has exhibited promising results in preclinical testing as a potential treatment for mitochondrial diseases and heart failure.
Research shows that this mitochondrial antioxidant peptide can eliminate oxidants and raise ATP levels, which keeps mitochondrial membrane potential (MMP) stable.
A recent study revealed a correlation between reducing neuroinflammation and increasing functional connectivity (FC) within hippocampus-relevant brain areas. This association was observed in hippocampus-relevant areas.
In addition, the study indicated that early administration of the anti-inflammatory drug SS-31 has a long-lasting effect on lowering the effects of lipopolysaccharide (LPS)-induced neuroinflammation. This was evidenced by the fact that early administration of SS-31 significantly reduced LPS-induced neuroinflammation.
Benefits of SS-31 Pre-Mixed Peptide Pen
The impact of SS-31 on mitochondrial activity and maintenance is being studied to determine its benefits on human health. Researchers have recently uncovered at least four promising advantages of SS-31 that may make it a valuable treatment for a wide range of conditions:
- Ability to reverse mitochondrial dysfunction
- Help increase endurance
- Help with cognitive impairment
- Reduces risk of heart disease
References:
https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-019-1627-9
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192202/
https://pubmed.ncbi.nlm.nih.gov/26944333/
https://pubmed.ncbi.nlm.nih.gov/23813215/
Benefits of Pharmagrade Store Pre-mixed Peptide Pens:
The pre-mixed pen kits include a cartridge, have a dosage dial, and single-use needle tips inside the case. As a result, the pens are easier, more accurate, and more convenient than a vial and syringe. Single cartridges can be used to top up your kit.
Other benefits include:
- Usability, especially for those new to research peptides.
- The pens are portable and convenient.
- The ability to set doses precisely using a dial.
- Reduces the stress of mixing correctly
- Because they are pre-mixed, they save time.
- There are various accessories to facilitate storage and use.
ALL PRODUCT INFORMATION AND ARTICLES ON THIS SITE ARE FOR EDUCATIONAL PURPOSES ONLY
DISCLAIMER: All products sold by PharmaGrade.Store are for research and laboratory use only. These products are not designed for use or consumption by humans or animals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such. By purchasing from our Website the buyer accepts and acknowledges the risks involved with handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. Handling and use of these products should be restricted to suitably qualified professionals.